Osteoporosis: the emperor has no clothes
T L N Järvinen1, K Michaëlsson2, P Aspenberg3
1Department of Orthopaedics and Traumatology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Journal of Internal Medicine
|March 27, 2015
Summary
Current low-trauma fracture prevention strategies for older adults are challenged. Osteoporosis is not always the cause, risk prediction is unreliable, and bone-targeted treatments show limited efficacy and potential risks.
Area of Science:
- Gerontology
- Orthopedics
- Pharmacology
Background:
- Current strategies for preventing low-trauma fractures in older adults are based on the assumptions that osteoporosis is the primary cause, high-risk individuals can be identified, and bone-targeted treatments are effective.
- These foundational assumptions are increasingly being questioned by recent research.
Purpose of the Study:
- To critically evaluate the current paradigms in low-trauma fracture prevention among older persons.
- To examine the limitations of osteoporosis as the sole etiological factor, the efficacy of current screening methods, and the effectiveness and safety of bone-targeted pharmacotherapy.
Main Methods:
- Review and analysis of existing literature on fracture pathophysiology, risk prediction, and treatment efficacy in older adults.
- Examination of data regarding the role of falls, frailty, and age-related decline in physical functioning.
- Evaluation of the evidence for bone-targeted pharmacotherapy, including clinical trial data and real-world studies, and associated adverse events.
Main Results:
- Falls are common in fracture patients, but osteoporosis is often absent; aging-related decline and frailty contribute significantly to fall risk.
- Current fracture risk prediction tools, including bone densitometry, fail to accurately identify a substantial proportion of individuals who will fracture.
- Evidence for bone-targeted pharmacotherapy is limited, particularly for hip fracture prevention in women over 80 and men, with questionable real-world efficacy and potential for serious adverse events.
Conclusions:
- The current prevention strategies for low-trauma fractures in older adults, relying on osteoporosis, screening, and pharmacotherapy, are not fully supported by evidence.
- Alternative approaches considering multifactorial causes like falls and frailty, alongside more accurate risk assessment and targeted interventions, are needed.
- Further research is required to develop effective and safe strategies for fracture prevention in the aging population.
Related Concept Videos
Bone Disorders
8.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.7K
Bone Remodeling
41.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.3K
Osteoclasts in Bone Remodeling
4.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.9K
Hormones and Bone Tissue
4.3K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.3K
What is the Skeletal System?
59.4K
Overview
59.4K
Role of Vitamins in Maintaining Bone Health
6.1K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
6.1K
